News | April 11, 2019

Culturing Cells Without Using Serum

amsbiopr241-image

AMSBIO announces XerumFree™ - a new concept in cell culture that allows you to culture cells without the use of serum.

XerumFree™ has been developed taking into account what is missing in traditional basal cell culture media to sustain growth of all cell types, which is a nutritional approach at the cellular level.

Containing no animal or human derived material, XerumFree™ is a serum replacement for all cell culture practices that is chemically defined thereby avoiding lot-to-lot variations and eliminating the need for testing new batches of serum. Since XerumFree™ does not contain hormones, cytokines or unknown serum compounds it cannot bias your research data. Further as XerumFree is animal vesicle free, it is an ideal cell culture medium for exosome research.

XerumFree™ has been designed to be easy to use, simply add it to your culture medium as you would do with fetal bovine serum (FBS). Examples of cells, which have successfully been cultured on XerumFree enriched medium include Liver epithelial cells, HaCaT, Primary human hepatocytes, Hybridoma, VERO, HEK293, CHO, HEP G2, HeLa and Human keratinocytes.

For further information please visit http://www.amsbio.com/xerumfree-defined-cell-culture.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.

For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology. For further information please visit www.amsbio.com.

SOURCE: AMSBIO